Unilever (ULVR.L) said this week it would raise prices to soften the hit from higher-than-expected costs driven by the Iran war, even as it reported first-quarter underlying sales growth ahead of analysts’ forecasts.
The London-listed maker of Dove soap and Axe deodorant, which has a market valuation of more than $120 billion, kept its 2026 sales and profit margin forecasts unchanged, indicating it hopes to weather the heightened economic uncertainty.
